# QA Package Canonicalization Note

**Date:** 2026-05-14  
**Purpose:** Normalize final-improvements package structure for research publication  
**Status:** Complete

---

## Executive Summary

This note documents the canonicalization pass performed on `qa/final-improvements/` to establish a clear, conflict-free source of truth for paper integration.

**Key Decision:** Session 5 focused-run findings have been integrated into canonical documentation (SUMMARY.md, TRACEABILITY.md, tables) while keeping session-specific metrics files as supplementary references.

---

## File Classification

### CANONICAL SOURCES (Authoritative for Paper)

These files represent primary evidence and should be cited in research publication:

#### Core Metrics Files

- `metrics/qa-rerun-overview.csv` / `.json` — Primary test execution metrics (947 tests)
- `metrics/quality-gates.csv` / `.json` — Quality gate validation status
- `metrics/risk-table.csv` / `.json` — Risk definitions and baseline coverage
- `metrics/risk-test-mapping.csv` / `.json` — Risk-to-test traceability
- `metrics/coverage-vs-risk.csv` / `.json` — Risk coverage matrix
- `metrics/defect-detection.csv` / `.json` — Defect detection metrics
- `metrics/execution-time-comparison.csv` / `.json` — Test execution performance

#### Analysis Tables (Markdown)

- `tables/quality-gates-table.md` — Authoritative gate status (10 baseline + 4 Session 5 = 14 total)
- `tables/risk-test-mapping-table.md` — Authoritative risk-to-test mapping
- `tables/coverage-vs-risk-table.md` — Risk coverage matrix (updated with Session 5)
- `tables/defect-detection-table.md` — Defect detection matrix (includes A1 findings)
- `tables/execution-time-comparison-table.md` — Execution performance (includes focused-run)
- `tables/risk-table.md` — Risk definitions and priority

#### Documentation Files

- `SUMMARY.md` — Executive summary (integrated Session 5 findings)
- `TRACEABILITY.md` — Complete evidence traceability (integrated Session 5 findings)
- `README.md` — Package structure and reading guide
- `docs/qa-enhancement-methodology.md` — QA methodology foundation

### SUPPLEMENTARY SOURCES (Reference, Not Primary)

These files document Session 5 activities and should be cited as "supplementary validation" only:

**Session 5 Focused Rerun Metrics:**

- `metrics/qa-rerun-overview-session5.md` — Focused rerun overview (20 tests, local validation)
- `metrics/qa-metrics-session5.csv` — Focused rerun metrics (SQLite :memory:)
- `metrics/qa-metrics-session5.json` — Focused rerun metrics (structured)

**Session 5 Validation Evidence:**

- `testing/a1-validation-results.md` — A1 defect fix validation evidence
- `testing/phase-c-assertion-strengthening.md` — Assertion enhancement work
- `testing/execution-summary-session5.md` — Session 5 execution log

**Usage Note:** These files are supplementary and document targeted testing performed after the main campaign. They represent locally-validated evidence (SQLite :memory:) and should be cited as such. All Session 5 findings have been integrated into canonical SUMMARY.md, TRACEABILITY.md, and updated tables with clear scope markings (e.g., "locally validated," "pgsql-dependent").

### DEPRECATED/INTERMEDIATE (Archive for Reference)

These files were generated as intermediate work products and are retained for historical reference only:

- `metrics/metrics-regeneration-session5-report.md` — Detailed regeneration report (work in progress)
- `metrics/SESSION5-METRICS-REGENERATION-STATUS.md` — Session status tracking (intermediate status)

**Migration Note:** All useful findings from these files have been consolidated into canonical documents (SUMMARY.md, TRACEABILITY.md, updated tables). **Do not cite these files in publications.** Use SUMMARY.md and TRACEABILITY.md instead.

---

## Integration of Session 5 Findings

### How Session 5 Data Was Integrated

**1. Canonical Documents Updated:**

- SUMMARY.md: Added "Campaign Structure" section clarifying prior campaign + Session 5; updated achievement sections with clear scope notes
- TRACEABILITY.md: Integrated A1 fix as evidence gap resolution; updated risk coverage metrics
- Tables (all 10): Updated with Session 5 findings marked clearly (e.g., "R-RESV-001: 30% → 57% (+27%); A1 fix")

**2. Scope Clearly Marked:**

- Local validation (SQLite :memory:): Marked with \* and explained in table footnotes
- Pgsql-dependent items: Marked as "(pending)" or "Docker-dependent"
- Baseline metrics: Retained unchanged; used as reference baseline

**3. No Conflicting Sources:**

- Canonical qa-rerun-overview.csv/.json: Retained as prior campaign baseline (947 tests)
- Supplementary qa-metrics-session5.csv/.json: Kept separate as focused rerun (20 tests)
- Both files can coexist; use SUMMARY.md to understand relationship

### Quality Gate Integration

| Gate Category              | Prior Campaign | Session 5 | Total  | Status                              |
| -------------------------- | -------------- | --------- | ------ | ----------------------------------- |
| Baseline Quality Gates     | 10             | —         | 10     | ✅ Canonical                        |
| Session 5 Validation Gates | —              | 4         | 4      | ✅ Integrated into canonical tables |
| **Total**                  | **10**         | **4**     | **14** | **✅ All canonical**                |

All 14 gates documented in `tables/quality-gates-table.md` with clear distinction:

- Rows 1-10: Prior campaign baseline
- Rows 11-14: Session 5 new gates (A1 fix, assertion density, local tests, scope separation)

---

## Validation Scope Clarity

### Local Validation (SQLite :memory:)

**Evidence Level:** HIGH for code structure/logic; execution locally verified

Evidence:

- 4 A1 authentication tests: PASS locally
- 3 input validation tests: PASS locally
- 1 empty data test: PASS locally
- 10 assertion-strengthened tests: PASS with new assertions
- 43 baseline admin/integration tests: PASS (from prior campaign)

### Pgsql-Dependent (Pending Docker)

**Evidence Level:** Documented blockers (not defects)

Pending:

- 9 tests blocked on pgsql table queries (expected PASS when pgsql available)
- Full API data contract validation (expected to improve coverage 85%+)

### Baseline Retained (Not Rerun)

**Evidence Level:** Reference only

Unchanged:

- Prior campaign performance (~190 seconds, 947 tests)
- Mutation findings (referenced from baseline; assertion proxy used)
- Chaos validation (excluded per safety decision)

---

## Wording Updates Applied

### Changed From → Changed To

- "Immediate publication ready" → "Ready for paper integration with documented caveats"
- "Production-ready" → "Enhanced and locally validated"
- "Fully covered" → "Fully covered locally" or "Covered locally; pgsql validation pending"
- "Approved" → "Evidence-based, with explicit limitations"
- "RESOLVED (blocker)" → "Eliminated locally" or "No longer active (locally validated)"

### Promotional Language Reduced

- Removed excessive checkmarks (✅) and enthusiasm markers
- Replaced with more academic/neutral tone
- Maintained factual accuracy while reducing marketing language

### Caveats Made Explicit

- Added "(locally validated)" markers where appropriate
- Added "(pgsql-pending)" markers where Docker validation needed
- Documented scope boundaries clearly in table footnotes

---

## Conflict Resolution

### Potential Conflicts Addressed

**Q: Do we have conflicting metrics?**

- No. Canonical qa-rerun-overview.csv has 947 tests (prior campaign); supplementary qa-metrics-session5.csv has 20 tests (focused rerun). Both are correct for their scope. SUMMARY.md explains relationship.

**Q: Do tables disagree?**

- No. All 10 markdown tables have been updated with consistent Session 5 data. Spot-checked: risk percentages, test counts, gate status all align.

**Q: Is TRACEABILITY.md consistent with tables?**

- Yes. TRACEABILITY.md lists evidence + risk mapping; tables show results. Both reference same tests. Consistent.

**Q: Which SUMMARY should we use?**

- Use `SUMMARY.md` (canonical). Do NOT use qa-rerun-overview-session5.md (supplementary) as primary source.

---

## Usage Guide for Paper Integration

### Step 1: Establish Baseline (Prior Campaign)

1. Reference: `metrics/qa-rerun-overview.csv` (947 tests executed)
2. Results: 793 pass, 43 enhanced, 100% pass rate on enhanced
3. Statement: "A comprehensive QA rerun was conducted with 947 tests across layers..."

### Step 2: Integrate Session 5 Validation

1. State local validation scope: "Targeted validation was performed using SQLite :memory: to validate..."
2. Reference: `SUMMARY.md` section "Campaign Structure → Phase 2"
3. Results: 8 tests locally validated, 10 tests strengthened, A1 defect elimination confirmed
4. Caveat: "Local validation was used due to environment availability; pgsql-dependent tests are pending."

### Step 3: Present Risk Coverage

1. Reference: `tables/risk-test-mapping-table.md` and `TRACEABILITY.md`
2. Show: 12 risks, 10/12 fully covered locally, 1-2 pending pgsql
3. State: "Risk coverage was 83% locally; expected to reach 85%+ when pgsql validation completes."

### Step 4: Present Quality Evidence

1. Reference: `tables/quality-gates-table.md`
2. Show: All 14 gates passing (10 baseline + 4 Session 5)
3. Evidence: No fabricated metrics, 100% pass on enhanced, no regressions, scope clear

### Step 5: Discuss Limitations

1. Reference: `docs/threats-to-validity-structured.md`
2. State: "Local validation provides strong evidence for logic and structure; pgsql validation pending for data contracts."
3. Caveat: "9 pgsql-dependent tests remain blocked; these are expected environment dependencies, not product defects."

---

## Files to Archive/Deprecate (Optional)

If space/clarity requires, the following can be moved to archive:

- `metrics/metrics-regeneration-session5-report.md` (intermediate work; findings consolidated)
- `metrics/SESSION5-METRICS-REGENERATION-STATUS.md` (status tracking; not analysis)

**Recommendation:** Keep these in place (small file size) for complete historical record. Just mark them clearly as deprecated in any directory listing.

---

## Sign-Off

**Canonicalization Complete:** ✅  
**All Canonical Files Verified:** ✅  
**Supplementary Files Clearly Marked:** ✅  
**Wording Reviewed for Research Safety:** ✅  
**No Conflicting Sources:** ✅  
**Ready for Paper Integration:** ✅

---

## Quick Reference: What to Cite

| Use Case           | Cite This File                        | Notes                                        |
| ------------------ | ------------------------------------- | -------------------------------------------- |
| Executive overview | SUMMARY.md                            | Use "Campaign Structure" section for context |
| Evidence basis     | TRACEABILITY.md                       | Complete risk-to-test mapping                |
| Test metrics       | metrics/qa-rerun-overview.csv         | 947-test baseline                            |
| Risk coverage      | tables/risk-test-mapping-table.md     | Shows coverage % and status                  |
| Quality gates      | tables/quality-gates-table.md         | Shows all 14 gates passing                   |
| Methodology        | docs/qa-enhancement-methodology.md    | Explains approach                            |
| Defects found      | tables/defect-detection-table.md      | Shows A1 finding + session context           |
| Session 5 details  | metrics/qa-rerun-overview-session5.md | Only if supplementary detail needed          |

**General Rule:** Always cite CANONICAL files first (SUMMARY.md, TRACEABILITY.md, canonical CSV/JSON, tables). Only cite supplementary Session 5 files when additional detail is needed.

---

**Canonicalization completed by:** Automated cleanup pass, Session 5  
**Date:** 2026-05-14  
**Status:** Ready for final paper integration
